Birgitt Schüle, MD, is an associate professor in pathology at Stanford University School of Medicine. Her lab uses genetics and stem-cell modeling to unlock neurodegenerative disease mechanisms and develop new therapeutic strategies for Parkinson’s disease (PD) and related disorders. Dr. Schüle received her medical degree from the Georg‐August University Göttingen and Medical University Lübeck, Germany (1993 ‐ 2001) and completed her doctoral degree in medicine (Dr. med.) in neurophysiology at the University of Göttingen (2001). During her neurology internship from 2001 to 2002 at the Medical University of Lübeck, Dr. Schüle studied inherited forms of PD and dystonia. Between 2003 and 2005, she was a postdoctoral fellow in the department of genetics at Stanford University School of Medicine. From 2005 to 2019, Dr. Schüle led three clinical research programs at the Parkinson’s Institute: neurogenetics, translational stem cell modeling and brain donation program.